top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
Tune Therapeutics Secures $175M to Advance Epigenetic Silencing Platform into Clinical Trials
Durham, NCÂ and Seattle, WA, January 12, 2025 (Business Wire) -- Tune Therapeutics has raised $175 million in Series B funding to...
Ribometrix Names William S. Marshall, Ph.D., as CEO to Drive Breakthrough RNA-Targeting Therapeutics
Durham, NC, January 09, 2025 (Globe newswire) -- Ribometrix has appointed Dr. William S. Marshall as CEO and Dr. Katie Warner as CSO,...
Kardigan Debuts with $300M and Visionary Team to Revolutionize Cardiovascular Medicine Through Personalized Therapies
San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure...
City Therapeutics Appoints Andrew Orth as CEO to Propel RNAi Innovation into Clinical Development
Cambridge, MA, January 07, 2025 (Business Wire) -- City Therapeutics, a biopharmaceutical leader in RNA interference (RNAi) medicine,...
Stryker to Acquire Inari Medical in $4.9B Deal, Expanding Leadership in Peripheral Vascular Care
Portage, MI and Irvine, CA, January 06, 2025 (Globe Newswire) -- Stryker’s acquisition of Inari Medical for $4.9 billion reinforces its...
Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants
Germantown, MD, December 27, 2024 (PRNewswire) -- Precigen, Inc. has entered into a securities purchase agreement for the sale of its...
VectorY Therapeutics Appoints Jim Scibetta as CEO and Expands U.S. Presence
Amsterdam, Netherlands and Boston, MA, December 20, 2024 (Business Wire) -- VectorY Therapeutics has appointed Jim Scibetta as its new...
Akamis Bio Secures $60M in Series A Prime Funding to Advance Oncology Pipeline
Cambridge, MA and Oxford, England, December 17, 2024 (Business Wire) -- Akamis Bio secured $60 million in Series A Prime funding and...
Borealis Biosciences Appoints Christian Hordo as CEO and Secures $30M in Series A Extension
Vancouver, British Columbia & Seattle, December 30, 2024 (Business Wire) -- Borealis Biosciences has appointed Christian Hordo as CEO...
AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B
San Francisco, CA, December 26, 2024 (PRNewswire) -- AusperBio has raised $73 million in Series B funding to advance its lead therapy,...
Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants
Santa Cruz, CA, December 13, 2024 (Yahoo) -- Capstan Medical has raised $110 million in a Series C funding round led by Eclipse, with...
Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation
Philadelphia, December 4, 2024 (PRNewswire) -- Dr. Vatsala Naageshwaran, an accomplished biopharmaceutical leader, has been appointed...
SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain TreatmentsÂ
South San Francisco, CA, December 18, 2024 (Business Wire) -- SiteOne Therapeutics has raised $100 million in Series C funding to...
Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth
San Diego, CA, December 12, 2024 (Business Wire) -- Pleno, Inc., a clinical and multi-omics diagnostics company, has appointed Dr. Vik...
AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform
North Chicago, IL and Madison, WI, December 13, 2024 (PRNewswire) -- AbbVie will acquire Nimble Therapeutics, gaining its lead oral...
Coherus Divests UDENYCA Franchise to Intas in $558.4M Deal to Fund Immuno-Oncology Expansion
Redwood City, CA, December 3, 2024 (Globe Newswire) -- Coherus is selling its UDENYCA franchise to Intas Pharmaceuticals for up to...
COUR Pharmaceuticals Secures $40M Upfront in Genentech Deal, Potential Milestones Exceed $900M
Chicago, December 3, 2024 (Globe Newswire) -- COUR Pharmaceuticals and Genentech have partnered to develop novel autoimmune disease...
BioFuse Medical Technologies Appoints Rick Early as CEO
Tampa, FL, December 4, 2024 (AccessWire) -- BioFuse Medical Technologies has announced significant leadership updates, appointing Rick...
Velentium Appoints Matt Hanks as CEO, Co-Founder Dan Purvis Named Board Chair to Propel Growth
Houston, TX, December 2, 2024 ( Business Wire ) -- Velentium has announced a leadership transition to support its continued growth,...
Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough
Warren, NJ, December 2, 2024 (Reuters) -- Novartis is acquiring PTC Therapeutics' Huntington’s disease drug, PTC518, for up to $2.9...
bottom of page